×
Correlates of Daytime Sleepiness in Patients With Posttraumatic Stress Disorder and Sleep Disturbance PDF
$ 40.00
Correlates of Daytime Sleepiness in Patients With Posttraumatic Stress Disorder and Sleep Disturbance PDF quantity
$ 40.00
×
Cost-Effectiveness of 12-Month Therapeutic Assertive Community Treatment as Part of Integrated Care Versus Standard Care in Patients With Schizophrenia Treated With Quetiapine Immediate Release (ACCESS Trial) PDF
$ 40.00
Cost-Effectiveness of 12-Month Therapeutic Assertive Community Treatment as Part of Integrated Care Versus Standard Care in Patients With Schizophrenia Treated With Quetiapine Immediate Release (ACCESS Trial) PDF quantity
$ 40.00
×
Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression: A Decade of Clinical Follow-Up PDF
$ 40.00
Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression: A Decade of Clinical Follow-Up PDF quantity
$ 40.00
×
The Diagnostic Challenge of Psychiatric Symptoms in Neurodegenerative Disease: Rates of and Risk Factors for Prior Psychiatric Diagnosis in Patients With Early Neurodegenerative Disease PDF
$ 40.00
The Diagnostic Challenge of Psychiatric Symptoms in Neurodegenerative Disease: Rates of and Risk Factors for Prior Psychiatric Diagnosis in Patients With Early Neurodegenerative Disease PDF quantity
$ 40.00
×
Longitudinal Examination of the Skeletal Effects of Selective Serotonin Reuptake Inhibitors and Risperidone in Boys PDF
$ 40.00
Longitudinal Examination of the Skeletal Effects of Selective Serotonin Reuptake Inhibitors and Risperidone in Boys PDF quantity
$ 40.00
×
Carnitine Levels in Valproic Acid-Treated Psychiatric Patients: A Cross-Sectional Study PDF
$ 40.00
Carnitine Levels in Valproic Acid-Treated Psychiatric Patients: A Cross-Sectional Study PDF quantity
$ 40.00
×
Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Acute Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study PDF
$ 40.00
Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Acute Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study PDF quantity
$ 40.00
×
Remission Rates With 3 Consecutive Antidepressant Trials: Effectiveness for Depressed Outpatients PDF
$ 40.00
Remission Rates With 3 Consecutive Antidepressant Trials: Effectiveness for Depressed Outpatients PDF quantity
$ 40.00
×
Complementary and Alternative Medicine for Major Depressive Disorder: A Meta-Analysis of Patient Characteristics, Placebo-Response Rates, and Treatment Outcomes Relative to Standard Antidepressants PDF
$ 40.00
Complementary and Alternative Medicine for Major Depressive Disorder: A Meta-Analysis of Patient Characteristics, Placebo-Response Rates, and Treatment Outcomes Relative to Standard Antidepressants PDF quantity
$ 40.00
×
Major Depressive Disorder Induced by Chronic Ketamine Abuse: A Case Report PDF
$ 40.00
Major Depressive Disorder Induced by Chronic Ketamine Abuse: A Case Report PDF quantity
$ 40.00
×
Use of Terazosin to Treat Trauma-Related Nightmares After a Failed Trial of Prazosin PDF
$ 40.00
Use of Terazosin to Treat Trauma-Related Nightmares After a Failed Trial of Prazosin PDF quantity
$ 40.00
×
Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder PDF
$ 40.00
Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart